Determination of Small Molecule ABAD Inhibitors Crossing Blood-Brain Barrier and Pharmacokinetics

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2014-08-11

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3233/JAD-140252PMID 24858403PMCID PMC4422494
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mitochondrial permeability transition pore is a potential drug target for neurodegeneration.

  2014cited by this paper
• Structure Based Design, Synthesis, Pharmacophore Modeling, Virtual Screening, and Molecular Docking Studies for Identification of Novel Cyclophilin D Inhibitors

  2014cited by this paper
• Identification of human ABAD inhibitors for rescuing Aβ-mediated mitochondrial dysfunction.

  2014influential reference
• Acetylcholinesterase Inhibitors: Structure Based Design, Synthesis, Pharmacophore Modeling, and Virtual Screening

  2013cited by this paper
• Structure‐Based Design and Synthesis of Benzothiazole Phosphonate Analogues with Inhibitors of Human ABAD‐Aβ for Treatment of Alzheimer’s Disease

  2013cited by this paper
• Mitochondrial Dysfunction and Immune Activation are Detectable in Early Alzheimer's Disease Blood

  2012cited by this paper
• Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.

  2012cited by this paper
• Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model.

  2011cited by this paper
• Design, Synthesis and Anti Colon Cancer Activity Evaluation of Phosphorylated Derivatives of Lamivudine (3TC)

  2011cited by this paper
• Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.

  2011cited by this paper
• Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model

  2010cited by this paper
• Synthesis, spectral characterization and biological evaluation of phosphorylated derivatives of galanthamine.

  2010cited by this paper
• Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

  2009cited by this paper
• RAGE-mediated signaling contributes to intraneuronal transport of amyloid-β and neuronal dysfunction

  2009cited by this paper
• Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.

  2008cited by this paper
• Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins

  2008cited by this paper
• Soluble Beta-Amyloid Leads to Mitochondrial Defects in Amyloid Precursor Protein and Tau Transgenic Mice

  2008cited by this paper
• A sensitive and selective RP-HPLC method for simultaneous determination of picroside-I and picroside-II in rat plasma and its application in pharmacokinetics studies.

  2007cited by this paper
• Development of an HPLC method for the monitoring of tricyclic antidepressants in biofluids.

  2007cited by this paper
• HPLC analysis and pharmacokinetics of icariin in rats.

  2007cited by this paper
• Quantitative determination of BMS-378806 in human plasma and urine by high-performance liquid chromatography/tandem mass spectrometry.

  2007cited by this paper
• Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Abeta interaction.

  2007cited by this paper
• Identification of small-molecule inhibitors of the Abeta-ABAD interaction.

  2006influential reference
• Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.

  2006cited by this paper
• Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase.

  2005cited by this paper
• Type 10 17beta-hydroxysteroid dehydrogenase catalyzing the oxidation of steroid modulators of gamma-aminobutyric acid type A receptors.

  2005cited by this paper
• Mitochondrial dysfunction and Alzheimer's disease: role of amyloid‐β peptide alcohol dehydrogenase (ABAD)

  2005cited by this paper
• Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.

  2005cited by this paper
• ABAD enhances Aβ‐induced cell stress via mitochondrial dysfunction

  2005cited by this paper
• Multiple functions of type 10 17β-hydroxysteroid dehydrogenase

  2005cited by this paper
• Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease

  2005cited by this paper
• Oxidative 3alpha-hydroxysteroid dehydrogenase activity of human type 10 17beta-hydroxysteroid dehydrogenase.

  2003cited by this paper
• Differentiation-dependent expression of 17beta-hydroxysteroid dehydrogenase, type 10, in the rodent testis: effect of aging in Leydig cells.

  2003cited by this paper
• Oxidative 3α-hydroxysteroid dehydrogenase activity of human type 10 17β-hydroxysteroid dehydrogenase

  2003cited by this paper
• 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene.

  2003cited by this paper
• Targeted drug delivery to the central nervous system via phosphonate derivatives (anionic delivery system for testosterone).

  2002cited by this paper
• Energy Hypometabolism in Posterior Cingulate Cortex of Alzheimer's Patients: Superficial Laminar Cytochrome Oxidase Associated with Disease Duration

  2001cited by this paper
• Function of human brain short chain L-3-hydroxyacyl coenzyme A dehydrogenase in androgen metabolism.

  2000cited by this paper
• Human Brain Short Chain l-3-Hydroxyacyl Coenzyme A Dehydrogenase Is a Single-domain Multifunctional Enzyme

  1999cited by this paper
• Role of ERAB/l-3-Hydroxyacyl-coenzyme A Dehydrogenase Type II Activity in Aβ-induced Cytotoxicity*

  1999cited by this paper
• Targeted drug delivery to the brain via phosphonate derivatives. I. Design, synthesis and evaluation of an anionic chemical delivery system for testosterone

  1998cited by this paper
• Targeted drug delivery to the brain via phosphonate derivatives II. Anionic chemical delivery system for zidovudine (AZT)

  1998cited by this paper
• A Human Brain l-3-Hydroxyacyl-coenzyme A Dehydrogenase Is Identical to an Amyloid β-Peptide-binding Protein Involved in Alzheimer’s Disease*

  1998cited by this paper
• An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease.

  1997cited by this paper
• An intracellular protein that binds amyloid-β peptide and mediates neurotoxicity in Alzheimer's disease

  1997cited by this paper

• Roles of Type 10 17β-Hydroxysteroid Dehydrogenase in Health and Disease

  2025cites this paper
• Parallelism in neurodegenerative biomarker tests: hidden errors and the risk of misconduct.

  2025cites this paper
• Involvement of Type 10 17β-Hydroxysteroid Dehydrogenase in the Pathogenesis of Infantile Neurodegeneration and Alzheimer’s Disease

  2023cites this paper
• Frentizole, a Nontoxic Immunosuppressive Drug, and Its Analogs Display Antitumor Activity via Tubulin Inhibition

  2023cites this paper
• Sulfur-containing therapeutics in the treatment of Alzheimer’s disease

  2021cites this paper
• Friend or enemy? Review of 17β‐HSD10 and its role in human health or disease

  2020cites this paper
• International Journal of Current Microbiology and Applied Sciences

  2020cites this paper
• Roles of Mitochondrial 17β-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer’s Disease

  2018cites this paper
• Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease.

  2018cites this paper
• Mitochondria as a Therapeutic Target for the Treatment of Alzheimer’s Disease

  2017cites this paper
• Mitochondrial drug targets in neurodegenerative diseases.

  2016cites this paper
• Photodynamic micelles for amyloid β degradation and aggregation inhibition.

  2016cites this paper
• SYNTHESIS, SPECTRAL CHARACTERIZATION AND ANTIMICROBIAL ACTIVITY OF NOVEL UREA/THIOUREA DERIVATIVES

  2015cites this paper
• Synthesis, Spectral Characterization and Anti Bacterial Activity of Novel Thiourea Analogues

  2015cites this paper
• Dysfunction of Endoplasmic Reticulum (ER) and Mitochondria (MT) in Alzheimer's Disease: The Role of the ER-MT Cross-Talk.

  2015cites this paper
• SYNTHESIS AND CHARACTERIZATION OF NOVEL PHOSPHORYLATED DERIVATES OF ZIDOVUDINE : ANTICANCER ACTIVITY AGAINST HUMAN BREAST CANCER CELL LINES ( MCF 7 )

  2015cites this paper
• A One-Pot Three Component Green Synthesis of 1-Aminoalkyl-2-Naphthols Using Grindstone Chemistry

  2015cites this paper
• Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes. Update 2014

  2014cites this paper